Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America
- PMID: 12617574
- DOI: 10.7326/0003-4819-137-5_part_2-200209031-00002
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America
Abstract
In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelines were updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended for clinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed or infected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure to opportunistic pathogens, preventing first episodes of disease by chemoprophylaxis or vaccination (primary prophylaxis), and preventing disease recurrence (secondary prophylaxis). Major changes since the last edition of the guidelines include 1) updated recommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4+ T lymphocyte counts have increased in response to antiretroviral therapy; 2) emphasis on screening all HIV-infected persons for infection with hepatitis C virus; 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regarding drug interactions, chiefly related to rifamycins and antiretroviral drugs; and 5) revised recommendations for immunizing HIV-infected adults and adolescents and HIV-exposed or infected children.
Similar articles
-
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.MMWR Recomm Rep. 2002 Jun 14;51(RR-8):1-52. MMWR Recomm Rep. 2002. PMID: 12081007
-
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).Infect Dis Obstet Gynecol. 2000;8(1):5-74. doi: 10.1155/S1064744900000028. Infect Dis Obstet Gynecol. 2000. PMID: 10741830 Free PMC article. Review. No abstract available.
-
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166. MMWR Recomm Rep. 2009. PMID: 19730409 Free PMC article.
-
1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.Clin Infect Dis. 1997 Oct;25 Suppl 3:S313-35. Clin Infect Dis. 1997. PMID: 9356832 No abstract available.
-
Prevention and treatment of common HIV-associated opportunistic complications.Prim Care. 1997 Sep;24(3):561-74. Prim Care. 1997. PMID: 9271692 Review.
Cited by
-
Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors.Invest New Drugs. 2014 Dec;32(6):1308-10. doi: 10.1007/s10637-014-0150-1. Epub 2014 Aug 14. Invest New Drugs. 2014. PMID: 25119297
-
Parasitic central nervous system infections in immunocompromised hosts.Clin Infect Dis. 2005 Apr 1;40(7):1005-15. doi: 10.1086/428621. Epub 2005 Mar 2. Clin Infect Dis. 2005. PMID: 15824993 Free PMC article. Review.
-
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):243-55. doi: 10.1007/s10096-004-1109-5. Epub 2004 Mar 13. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15024625 Review.
-
Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.Can J Infect Dis Med Microbiol. 2004 Nov;15(6):327-35. doi: 10.1155/2004/369390. Can J Infect Dis Med Microbiol. 2004. PMID: 18159510 Free PMC article.
-
Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?Frontline Gastroenterol. 2016 Jul;7(3):222-226. doi: 10.1136/flgastro-2014-100458. Epub 2014 Sep 22. Frontline Gastroenterol. 2016. PMID: 28839859 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials